These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21315202)

  • 21. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Special cases in acute heart failure syndromes: atrial fibrillation and wide complex tachycardia.
    Pang PS; Gheorghiade M
    Heart Fail Clin; 2009 Jan; 5(1):113-23, vii-viii. PubMed ID: 19026391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach.
    Pang PS; Cleland JG; Teerlink JR; Collins SP; Lindsell CJ; Sopko G; Peacock WF; Fonarow GC; Aldeen AZ; Kirk JD; Storrow AB; Tavares M; Mebazaa A; Roland E; Massie BM; Maisel AS; Komajda M; Filippatos G; Gheorghiade M;
    Eur Heart J; 2008 Mar; 29(6):816-24. PubMed ID: 18310669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.
    Blair JE; Zannad F; Konstam MA; Cook T; Traver B; Burnett JC; Grinfeld L; Krasa H; Maggioni AP; Orlandi C; Swedberg K; Udelson JE; Zimmer C; Gheorghiade M;
    J Am Coll Cardiol; 2008 Nov; 52(20):1640-8. PubMed ID: 18992654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized clinical trials with levosimendan.
    Mebazaa A; Barraud D; Welschbillig S
    Am J Cardiol; 2005 Sep; 96(6A):74G-9G. PubMed ID: 16181826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities.
    Peacock WF; Braunwald E; Abraham W; Albert N; Burnett J; Christenson R; Collins S; Diercks D; Fonarow G; Hollander J; Kellerman A; Gheorghiade M; Kirk D; Levy P; Maisel A; Massie BM; O'Connor C; Pang P; Shah M; Sopko G; Stevenson L; Storrow A; Teerlink J
    J Am Coll Cardiol; 2010 Jul; 56(5):343-51. PubMed ID: 20650354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of phase II trial designs used in studies of molecular targeted agents: outcomes and predictors of success in phase III.
    El-Maraghi RH; Eisenhauer EA
    J Clin Oncol; 2008 Mar; 26(8):1346-54. PubMed ID: 18285606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial.
    Collins SP; Lindsell CJ; Pang PS; Storrow AB; Peacock WF; Levy P; Rahbar MH; Del Junco D; Gheorghiade M; Berry DA
    Am Heart J; 2012 Aug; 164(2):138-45. PubMed ID: 22877798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel designs and end points for phase II clinical trials.
    Adjei AA; Christian M; Ivy P
    Clin Cancer Res; 2009 Mar; 15(6):1866-72. PubMed ID: 19276272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic therapy for acute heart failure.
    Tang WH
    Cardiol Clin; 2007 Nov; 25(4):539-51; vi. PubMed ID: 18063158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early pharmacological treatment of acute heart failure syndromes: a systematic review of clinical trials.
    De Luca L; Fonarow GC; Mebazaa A; Shin DD; Collins SP; Swedberg K; Gheorghiade M
    Acute Card Care; 2007; 9(1):10-21. PubMed ID: 17453534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New investigational drugs for the management of acute heart failure syndromes.
    Tamargo J; Amorós I; Barana A; Caballero R; Delpón E
    Curr Med Chem; 2010; 17(4):363-90. PubMed ID: 20015042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute heart failure syndromes: initial management.
    Pang PS
    Emerg Med Clin North Am; 2011 Nov; 29(4):675-88, v. PubMed ID: 22040699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.